Literature DB >> 6308044

Dynamic regulation of leukocyte beta adrenergic receptor-agonist interactions by physiological changes in circulating catecholamines.

R D Feldman, L E Limbird, J Nadeau, G A FitzGerald, D Robertson, A J Wood.   

Abstract

beta-Adrenergic receptors on human mononuclear leukocytes were assessed using [125I]iodohydroxybenzylpindolol binding. Subjects were studied supine and after being ambulatory, a maneuver that increases plasma catecholamines approximately two-fold. beta-Receptor affinity for agonists, measured by the competition of [125I]iodohydroxybenzylpindolol binding by (-)isoproterenol was significantly reduced with ambulation and this reduction was associated with a reduction in the proportion of beta-receptors binding agonist with a high affinity from a mean (+/- SEM) of 42 +/- 5 to 24 +/- 2% (P less than 0.01). In a parallel series, beta-adrenergic-stimulated adenylate cyclase activity was also reduced with postural change from 4.6 +/- 1.1 to 2.4 +/- 0.6 pmol [32P]cAMP/min per mg protein (P less than 0.05) after ambulation. Similar reductions in the proportion of receptors binding agonist with a high affinity were seen after infusion of norepinephrine. We conclude that the maneuver of ambulation reduces leukocyte beta-receptor responsiveness and affinity for agonists, probably by the effect of increased plasma catecholamines mediating an uncoupling of the beta-receptor-adenylate cyclase complex.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6308044      PMCID: PMC1129171          DOI: 10.1172/jci110954

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  Subsensitivity of adenylate cyclase and decreased beta-adrenergic receptor binding after chronic exposure to (minus)-isoproterenol in vitro.

Authors:  J Mickey; R Tate; R J Lefkowitz
Journal:  J Biol Chem       Date:  1975-07-25       Impact factor: 5.157

2.  Role of beta-adrenergic receptors in catecholamine-induced desensitization of adenylate cyclase in human astrocytoma cells.

Authors:  G L Johnson; B B Wolfe; T K Harden; P B Molinoff; J P Perkins
Journal:  J Biol Chem       Date:  1978-03-10       Impact factor: 5.157

3.  A simplified radiometric assay for plasma norepinephrine and epinephrine.

Authors:  P G Passon; J D Peuler
Journal:  Anal Biochem       Date:  1973-02       Impact factor: 3.365

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  A highly sensitive adenylate cyclase assay.

Authors:  Y Salomon; C Londos; M Rodbell
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

6.  Human synoviocytes: activation and desensitization by prostaglandins and 1-epinephrine.

Authors:  D S Newcombe; C P Ciosek; Y Ishikawa; J V Fahey
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

7.  Reversal of catecholamine refractoriness by inhibitors of RNA and protein synthesis.

Authors:  J DeVellis; G Brooker
Journal:  Science       Date:  1974-12-27       Impact factor: 47.728

8.  Agonist-specific refractoriness induced by isoproterenol. Studies with mutant cells.

Authors:  M Shear; P A Insel; K L Melmon; P Coffino
Journal:  J Biol Chem       Date:  1976-12-10       Impact factor: 5.157

9.  Properties of adenylate cyclase of lymphoid cells.

Authors:  M H Makman
Journal:  Proc Natl Acad Sci U S A       Date:  1971-05       Impact factor: 11.205

10.  Rapid changes in rat pineal beta-adrenergic receptor: alterations in l-(3H)alprenolol binding and adenylate cyclase.

Authors:  J W Kebabian; M Zatz; J A Romero; J Axelrod
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

View more
  13 in total

1.  Up-regulation of beta-adrenoceptors on circulating mononuclear cells after reduction of central sympathetic outflow by clonidine in normal subjects.

Authors:  Y Zoukos; T Thomaides; D V Pavitt; J P Leonard; M L Cuzner; C J Mathias
Journal:  Clin Auton Res       Date:  1992-06       Impact factor: 4.435

Review 2.  Physiological changes due to age. Pharmacodynamic changes of drug action and implications for therapy.

Authors:  P P Lamy
Journal:  Drugs Aging       Date:  1991 Sep-Oct       Impact factor: 3.923

3.  Peripheral mononuclear leucocyte beta adrenoceptors and non-specific bronchial responsiveness to methacholine in young and elderly normal subjects and asthmatic patients.

Authors:  M J Connolly; J J Crowley; C P Nielson; N B Charan; R E Vestal
Journal:  Thorax       Date:  1994-01       Impact factor: 9.139

4.  Beta-adrenoceptor changes in human lymphocytes, induced by dynamic exercise.

Authors:  O E Brodde; A Daul; N O'Hara
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-02       Impact factor: 3.000

5.  Low sodium diet corrects the defect in lymphocyte beta-adrenergic responsiveness in hypertensive subjects.

Authors:  R D Feldman; W J Lawton; W L McArdle
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

6.  Plasma catecholamine modulation of alpha 2 adrenoreceptor agonist affinity and sensitivity in normotensive and hypertensive human platelets.

Authors:  A S Hollister; J Onrot; S Lonce; J H Nadeau; D Robertson
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

7.  Hormone and forskolin-stimulated cyclic AMP accumulation in human lymphocytes: reliability of longitudinal time measurements.

Authors:  R P Ebstein; J Mintzer; Y Lipschitz; Z Shemesh; J Stessman
Journal:  Experientia       Date:  1986-07-15

8.  Leukocyte beta-receptor alterations in hypertensive subjects.

Authors:  R D Feldman; L E Limbird; J Nadeau; D Robertson; A J Wood
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

9.  Homologous upregulation of human arterial alpha-adrenergic responses by guanadrel.

Authors:  R V Hogikyan; M A Supiano
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

10.  Acute reduction in human platelet alpha 2-adrenoreceptor affinity for agonist by endogenous and exogenous catecholamines.

Authors:  A S Hollister; G A FitzGerald; J H Nadeau; D Robertson
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.